About ATS Biotech
Advanced
Treatment
Solutions Biotech, Inc.
(ATS) was founded in 2005, for the purpose of developing and commercializing leading edge proprietary consumer, healthcare products that provide Advanced Treatment Solutions for pain and inflammation.
The inception of ATS occurred following the realization of an unmet need within sports medicine. The Founder,
Michael Krog who is a stakeholder within the soccer community recognized that an improved treatment solution for common athletic injuries such as sprains, strains and fractures was needed. Ultimately this solution would be beneficial to a wide range of pain and inflammatory related cases. ATS Biotech has since developed two proprietary hydrogel technologies that satisfy several unmet needs within the pain and inflammation markets.
The foundation of ATS Biotech’s success is derived from the input of scientists, professional athletes, celebrities and business executives who as a team form ATS Biotech’s extensive Global Network. The focus of ATS moving forward is to commercialize its cryotherapeutic hydrogel technology, while continuing research and development of pipeline products.